Search

Search Constraints

You searched for: Author/Creator Gilbert, Mark R

Search Results

51. Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma. Issue 2 (12th July 2018)

52. Programmed Death Ligand 1 Is a Negative Prognostic Marker in Recurrent Isocitrate Dehydrogenase-Wildtype Glioblastoma. Issue 2 (1st August 2019)

53. Protein phosphatase 2A inhibition enhances radiation sensitivity and reduces tumor growth in chordoma. Issue 6 (23rd December 2017)

55. Short delay in initiation of radiotherapy for patients with glioblastoma-effect of concurrent chemotherapy: a secondary analysis from the NRG Oncology/Radiation Therapy Oncology Group database. Issue 7 (15th February 2018)

57. Systematic review on the use of patient-reported outcome measures in brain tumor studies: part of the Response Assessment in Neuro-Oncology Patient-Reported Outcome (RANO-PRO) initiative. Issue 4 (13th February 2021)

58. Targeting hypoxia downstream signaling protein, CAIX, for CAR T-cell therapy against glioblastoma. Issue 11 (4th July 2019)

59. The Montreal Cognitive Assessment (MoCA) in neuro-oncology: A pilot study of feasibility and utility in telehealth and in-person clinical assessments. Issue 5 (14th May 2022)